Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: In vivo studies

Neurobiology of Disease

Volumn 79, Issue , 2015, Pages 41-50

  Vázquez, Carmen ^a   Tolón, Rosa María ^a   Pazos, María Ruth ^a,b   Moreno, Marta ^a   Koester, Erin C ^c   Cravatt, Benjamin F ^d   Hillard, Cecilia J ^c   Romero, Julián ^a,e  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e UNIVERSIDAD FRANCISCO DE VITORIA   (Spain)

Author keywords

Astrocytes; Endocannabinoids; Hemichannels; Microglia; Multiphoton microscopy; Neuroprotection

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ADENOSINE TRIPHOSPHATE; APYRASE; CANNABINOID 1 RECEPTOR; CONNEXIN 43; ENDOCANNABINOID; FATTY ACID AMIDASE; FLUFENAMIC ACID; N OLEOYLETHANOLAMINE; PALMIDROL; 2-ARACHIDONYLGLYCEROL; ACYLGLYCEROL; AMIDASE; AMIDE; ANANDAMIDE; ANTIINFLAMMATORY AGENT; ARACHIDONIC ACID DERIVATIVE; ETHANOLAMINE DERIVATIVE; FATTY-ACID AMIDE HYDROLASE; GJA1 PROTEIN, MOUSE; OLEIC ACID; PALMITIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CONTROLLED STUDY; ENZYME DEGRADATION; EXCITOTOXICITY; FEMALE; GENE INACTIVATION; GLIA CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROGLIA; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN; BRAIN INJURY; DISEASE MODEL; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; LASER; METABOLISM; TRANSGENIC MOUSE;

ADENOSINE TRIPHOSPHATE; AMIDOHYDROLASES; ANIMALS; ANTI-INFLAMMATORY AGENTS; APYRASE; ARACHIDONIC ACIDS; ASTROCYTES; BRAIN; BRAIN INJURIES; CONNEXIN 43; DISEASE MODELS, ANIMAL; ENDOCANNABINOIDS; ETHANOLAMINES; FLUFENAMIC ACID; GLYCERIDES; LASERS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MICROGLIA; OLEIC ACIDS; PALMITIC ACIDS; POLYUNSATURATED ALKAMIDES; RECEPTOR, CANNABINOID, CB1;

EID: 84928599358     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2015.04.005     Document Type: Article

References (53)

1. Ativie F., Albayram O., Bach K., Pradier B., Zimmer A., Bilkei-Gorzo A. Enhanced microglial activity in FAAH-/- animals. Life Sci. 2014, 10.1016/j.lfs.2014.12.016.
2. Atwood B.K., Mackie K. CB2: a cannabinoid receptor with an identity crisis. Br. J. Pharmacol. 2010, 160:467-479.
3. Benito C., Tolón R.M., Pazos M.R., Núñez E., Castillo A.I., Romero J. Cannabinoid CB2 receptors in human brain inflammation. Br. J. Pharmacol. 2008, 153:277-285.
4. Benito C., Tolón R.M., Castillo A.I., Ruiz-Valdepeñas L., Martínez-Orgado J.A., Fernández-Sánchez F.J., Vázquez C., Cravatt B.F., Romero J. β-Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB1 or CB2 receptors. Br. J. Pharmacol. 2012, 166:1474-1489.
5. Binder D.K., Papadopoulos M.C., Haggie P.M., Verkman A.S. In vivo measurement of brain extracellular space diffusion by cortical surface photobleaching. J. Neurosci. 2004, 24:8049-8056.
6. Blankman J.L., Cravatt B.F. Chemical probes of endocannabinoid metabolism. Pharmacol. Rev. 2013, 19:849-871.
7. Bosier B., Bellocchio L., Metna-Laurent M., Soria-Gomez E., Matias I., Hebert-Chatelain E., Cannich A., Maitre M., Leste-Lasserre T., Cardinal P., Mendizabal-Zubiaga J., Canduela M.J., Requero L., Hermans E., Grandes P., Cota D., Marsicano G. Astroglial CB1 cannabinoid receptors regulate leptin signaling in mouse brain astrocytes. Mol. Metab. 2013, 2:393-404.
8. Bosier B., Muccioli G.G., Lambert D.M. The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB1- and FAAH-independent mechanisms. Br. J. Pharmacol. 2013, 169:794-807.
9. Buczynski M.W., Parsons L.H. Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls. Br. J. Pharmacol. 2010, 160:423-442.
10. Cardona A.E., Pioro E.P., Sasse M.E., Kostenko V., Cardona S., Dijkstra I.M., Huang D., Kidd G., Dombrowski S., Dutta R., Lee J.C., Cook D.N., Jung S., Lira S.A., Littman D.R., Ransohoff R.M. Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 2006, 9:917-924.
11. Contreras J.E., Sáez J.C., Bukauskas F.F., Bennett M.V. Gating and regulation of connexin 43 (Cx43) hemichannels. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:11388-11393.
12. Correa F., Mestre L., Docagne F., Borrell J., Guaza C. The endocannabinoid anandamide from immunomodulation to neuroprotection. Implications for multiple sclerosis. Vitam. Horm. 2009, 81:207-230.
13. Cravatt B.F., Demarest K., Patricelli M.P., Bracey M.H., Giang D.K., Martin B.R., Lichtman A. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:9371-9376.
14. Davalos D., Grutzendler J., Yang G., Kim J.V., Zuo Y., Jung S., Littman D.R., Dustin M.L., Gan W.B. ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci. 2005, 8:752-758.
15. Eljaschewitsch E., Witting A., Mawrin C., Lee T., Schmidt P.M., Wolf S., Hoertnagl H., Raine C.S., Schneider-Stock R., Nitsch R., Ullrich O. The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. Neuron 2006, 49:67-79.
16. Fernandez-Ruiz J.J., Gonzalez S., Romero J., Ramos J.A. Cannabinoids in neurodegeneration and neuroprotection. Cannabinoids as Therapeutics 2005, 79-109. Birkhäuser Verlag, Switzerland. R. Mechoulam (Ed.).
17. Fowler C.J., Rojo M.L., Rodriguez-Gaztelumendi A. Modulation of the endocannabinoid system: neuroprotection or neurotoxicity?. Exp. Neurol. 2010, 224:37-47.
18. Franklin A., Parmentier-Batteur S., Walter L., Greenberg D.A., Stella N. Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility. J. Neurosci. 2003, 23:7767-7775.
19. Froger N., Orellana J.A., Cohen-Salmon M., Ezan P., Amigou E., Sáez J.C., Giaume C. Cannabinoids prevent the opposite regulation of astroglial connexin43 hemichannels and gap junction channels induced by pro-inflammatory treatments. J. Neurochem. 2009, 111:1383-1397.
20. Giaume C., Leybaert L., Naus C.C., Saez J.C. Connexin and pannexin hemichannels in brain glial cells: properties, pharmacology, and roles. Front. Pharmacol. 2013, 4:88.
21. Hansson E., Rönnbäck L. Glial neuronal signaling in the central nervous system. FASEB J. 2003, 17:341-348.
22. Haynes S.E., Hollopeter G., Yang G., Kurpius D., Dailey M.E., Gan W.B., Julius D. The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat. Neurosci. 2006, 9:1512-1519.
23. Hines D.J., Hines R.M., Mulligan S.J., Macvicar B.A. Microglia processes block the spread of damage in the brain and require functional chloride channels. Glia 2009, 57:1610-1618.
24. Huang C., Han X., Li X., Lam E., Peng W., Lou N., Torres A., Yang M., Garre J.M., Tian G.F., Bennett M.V., Nedergaard M., Takano T. Critical role of connexin 43 in secondary expansion of traumatic spinal cord injury. J. Neurosci. 2012, 32:3333-3338.
25. Jung S., Aliberti J., Graemmel P., Sunshine M.J., Kreutzberg G.W., Sher A., Littman D.R. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol. 2000, 20:4106-4114.
26. Karpuk N., Burkovetskaya M., Fritz T., Angle A., Kielian T. Neuroinflammation leads to region-dependent alterations in astrocyte gap junction communication and hemichannel activity. J. Neurosci. 2011, 31:414-425.
27. Kawahara H., Drew G.M., Christie M.J., Vaughan C.W. Inhibition of fatty acid amide hydrolase unmasks CB1 receptor and TRPV1 channel-mediated modulation of glutamatergic synaptic transmission in midbrain periaqueductal grey. Br. J. Pharmacol. 2011, 163:1214-1222.
28. Kim J.V., Dustin M.L. Innate response to focal necrotic injury inside the blood-brain barrier. J. Immunol. 2006, 177:5269-5277.
29. Lopez-Rodriguez A.B., Mateos Vicente B., Romero-Zerbo S.Y., Rodriguez-Rodriguez N., Bellini M.J., Rodriguez de Fonseca F., Bermudez-Silva F.J., Azcoitia I., Garcia-Segura L.M., Viveros M.P. Estradiol decreases cortical reactive astrogliosis after brain injury by a mechanism involving cannabinoid receptors. Cereb. Cortex 2011, 21:2046-2055.
30. Mancuso J.J., Larson A.M., Wensel T.G., Saggau P. Multiphoton adaptation of a commercial low-cost confocal microscope for live tissue imaging. J. Biomed. Opt. 2009, 14:034048.
31. Maresz K., Carrier E.J., Ponomarev E.D., Hillard C.J., Dittel B.N. Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli. J. Neurochem. 2005, 95:437-445.
32. Marsicano G., Goodenough S., Monory K., Hermann H., Eder M., Cannich A., Azad S.C., Cascio M.G., Gutierrez S.O., van der S.M., Lopez-Rodriguez M.L., Casanova E., Schutz G., Zieglgansberger W., Di M V., Behl C., Lutz B. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 2003, 302:84-88.
33. Mechoulam R., Lichtman A.H. Neuroscience. Stout guards of the central nervous system. Science 2003, 302:65-67.
34. Nagayama T., Sinor A.D., Simon R.P., Chen J., Graham S.H., Jin K., Greenberg D.A. Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures. J. Neurosci. 1999, 19:2987-2995.
35. Navarrete M., Araque A. Endocannabinoids mediate neuron-astrocyte communication. Neuron 2008, 57:883-893.
36. Navarrete M., Araque A. Endocannabinoids potentiate synaptic transmission through stimulation of astrocytes. Neuron 2010, 68:113-126.
37. Nimmerjahn A., Kirchhoff F., Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005, 308:1314-1318.
38. Orellana J.A., Froger N., Ezan P., Jiang J.X., Bennett M.V., Naus C.C., Giaume C., Sáez J.C. ATP and glutamate released via astroglial connexin 43 hemichannels mediate neuronal death through activation of pannexin 1 hemichannels. J. Neurochem. 2011, 118:826-840.
39. Orellana J.A., von Bernhardi R., Giaume C., Saez J.C. Glial hemichannels and their involvement in aging and neurodegenerative diseases. Rev. Neurosci. 2012, 23:163-177.
40. Pamplona F.A., Ferreira J., Menezes de Lima O., Duarte F.S., Bento A.F., Forner S., Villarinho J.G., Bellochio L., Wotjak C.T., Lerner R., Monory K., Lutz B., Canetti C., Matias I., Calito J.B., Marsicano G., Guimaraes M.Z., Takahashi R.N. Anti-inflammatory lipoxin A4 is an endogenous allosteric enhancer of CB1 cannabinoid receptor. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:21134-21139.
41. Panikashvili D., Simeonidou C., Ben Shabat S., Hanus L., Breuer A., Mechoulam R., Shohami E. An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature 2001, 413:527-531.
42. Patel S., Carrier E.J., Ho W.S., Rademacher D.J., Cunningham S., Reddy D.S., Falck J.R., Cravatt B.F., Hillard C.J. The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity. J. Lipid Res. 2005, 46:342-349.
43. Patel S., Roelke C.T., Rademacher D.J., Hillard C.J. Inhibition of restraint stress-induced neural and behavioral activation by endogenous cannabinoid signaling. Eur. J. Neurosci. 2005, 21:1057-1069.
44. Pazos M.R., Núñez E., Benito C., Tolón R.M., Romero J. Functional neuroanatomy of the endocannabinoid system. Pharmacol. Biochem. Behav. 2005, 81:239-247.
45. Pertwee R.G., Howlett A.C., Abood M.E., Alexander S.P., Di Marzo V., Elphick M.R., Greasley P.J., Hansen H.S., Kunos G., Mackie K., Mechoulam R., Ross R.A. International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2. Pharmacol. Rev. 2010, 62:588-631.
46. Retamal M.A., Froger N., Palacios-Prado N., Ezan P., Sáez P.J., Sáez J.C., Giaume C. Cx43 hemichannels and gap junction channels in astrocytes are regulated oppositely by proinflammatory cytokines released from activated microglia. J. Neurosci. 2007, 27:13781-13792.
47. Romero J., Hillard C.J., Calero M., Rabano A. Fatty acid amide hydrolase localization in the human central nervous system: an immunohistochemical study. Mol. Brain Res. 2002, 100:85-93.
48. Ruiz-Valdepeñas L., Martínez-Orgado J.A., Benito C., Millán A., Tolón R.M., Romero J. Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study. J. Neuroinflammation 2011, 8:5.
49. Shen M., Piser T.M., Seybold V.S., Thayer S.A. Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J. Neurosci. 1996, 16:4322-4334.
50. Stella N. Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas. Glia 2010, 58:1017-1030.
51. Venance L., Piomelli D., Glowinski J., Giaume C. Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes. Nature 1995, 376:590-594.
52. Walter L., Franklin A., Witting A., Wade C., Xie Y., Kunos G., Mackie K., Stella N. Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J. Neurosci. 2003, 23:1398-1405.
53. Wolf Y., Yona S., Kim K.W., Jung S. Microglia, seen from the Cx3cr1 angle. Front. Cell. Neurosci. 2013, 7:26.